Get more Mail & Guardian
Subscribe or Login

Africa CDC prioritises full vaccination over Pfizer booster

The priority for Africa is to achieve herd immunity for Covid-19, the head of the Africa Centres for Disease Control and Prevention (Africa CDC) said at a weekly briefing on Thursday.

Cameroonian virologist and director of the continent’s public health agency, Dr John Nkengasong, said Africa CDC was confident that the African Union would achieve its vaccination goals by the end of the year. 

Asked if the Africa CDC would endorse a third dose of Pfizer, after the drug company Pfizer announced the study of a third booster vaccine on 24 May, Nkengasong said the continent’s health authorities were still focused on the first and second doses first. 

The African regional director for the World Health Organisation, Dr Matshidiso Moeti, said possibly dispensing a third dose would first entail evaluation of its necessity and efficacy.

In response to a question about fully vaccinated people still testing positive for Covid-19, Moeti stressed that the vaccines did not completely shield individuals from getting the virus, but did reduce the viral load, leading to lower rates of transmission and reduced chances of falling severely ill or dying.

She said it was crucial for African countries to ramp up the rate of vaccinations and increase confidence in the drugs, so that the continent could reach its inoculation targets.

The latest figures show that 6.5-million cases of Covid-19 have been reported in Africa, out of which some 867 000 people have died, Nkengasong said.

“The concept and philosophy of the African Union is that we leave no country behind, because we are not going to win this battle against Covid-19 on the continent if any country is left behind,” he added.

Moeti said 820-million vaccine doses were needed to reach the African Union’s year-end target.

Covax (Covid-19 Vaccines Global Access), a worldwide initiative aimed at equitable access to vaccines, hopes to deliver 520-million doses to African countries by the end of 2021, and the African Union is set to start distributing the 400-million Johnson & Johnson doses acquired by the African Vaccine Acquisition Taskforce, Moeti said.

Subscribe for R500/year

Thanks for enjoying the Mail & Guardian, we’re proud of our 36 year history, throughout which we have delivered to readers the most important, unbiased stories in South Africa. Good journalism costs, though, and right from our very first edition we’ve relied on reader subscriptions to protect our independence.

Digital subscribers get access to all of our award-winning journalism, including premium features, as well as exclusive events, newsletters, webinars and the cryptic crossword. Click here to find out how to join them and get a 57% discount in your first year.

Related stories


If you’re reading this, you clearly have great taste

If you haven’t already, you can subscribe to the Mail & Guardian for less than the cost of a cup of coffee a week, and get more great reads.

Already a subscriber? Sign in here


Subscribers only

‘The children cannot cope any more’: Suicide in Calvinia highlights...

How Covid-19 has intensified the physical and emotional burdens placed on children’s shoulders.

Capitec Bank flies high above Viceroy’s arrow

The bank took a knock after being labelled a loan shark by the short seller, but this has not stymied its growth

More top stories

Covid-19: No vaccine booster shots needed yet

Scientists agree it is important to get most of the population vaccinated before giving booster jabs

The convenient myth of an Africa spared from Covid-19

There are few, if any, studies to support Pfizer chief executive’s assertion that the global south would be more vaccine-hesitant than the north

Council wants Hawks, SIU probe into BAT’s Zimbabwe scandal

The cigarette maker has been accused of giving up to $500 000 in bribes and spying on competitors

press releases

Loading latest Press Releases…